Factor VIII and Functional Protein C Activity in Critically Ill Patients With Coronavirus Disease 2019: A Case Series.
A A Pract
; 14(7): e01236, 2020 May.
Article
in English
| MEDLINE | ID: covidwho-601387
ABSTRACT
Critically ill patients with coronavirus disease 2019 (COVID-19) have been observed to be hypercoagulable, but the mechanisms for this remain poorly described. Factor VIII is a procoagulant factor that increases during inflammation and is cleaved by activated protein C. To our knowledge, there is only 1 prior study of factor VIII and functional protein C activity in critically ill patients with COVID-19. Here, we present a case series of 10 critically ill patients with COVID-19 who had severe elevations in factor VIII activity and low normal functional protein C activity, which may have contributed to hypercoagulability.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Respiratory Distress Syndrome
/
Factor VIII
/
Protein C
/
Coronavirus Infections
/
Thrombophilia
Type of study:
Observational study
Language:
English
Journal:
A A Pract
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS